首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

數位PCR市場規模、佔有率和成長分析（按類型、產品類型、技術、適應症、應用、最終用戶和地區分類）－產業預測（2026-2033年）

市場調查報告書

商品編碼

1897843

數位PCR市場規模、佔有率和成長分析（按類型、產品類型、技術、適應症、應用、最終用戶和地區分類）－產業預測（2026-2033年）

Digital PCR Market Size, Share, and Growth Analysis, By Type (Quantitative, Digital), By Product (Consumables & Reagents, Digital PCR Instruments), By Technology, By Indication, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，數位 PCR 市場規模將達到 90.9 億美元，到 2025 年將達到 99.5 億美元，到 2033 年將達到 205.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 9.5%。

全球數位PCR市場正經歷顯著成長，這主要得益於對精準、靈敏的核酸定量和分析需求的不斷成長。這項創新技術憑藉其無與倫比的準確性和靈敏度，在研究、疾病診斷和基因檢測中發揮著至關重要的作用。該市場旨在為醫療專業人員和研究人員提供先進的分子診斷解決方案，以提供可靠的結果，從而改善患者照護並促進科學進步。市場的主要促進因素包括感染疾病和遺傳疾病發病率的上升、對個人化醫療日益成長的需求以及基因組研究的重大進展。儘管高成本和用戶知識有限等挑戰依然存在，但多重數位PCR檢測和與次世代定序的整合等進步正在為數位PCR領域創造一個穩健且不斷發展的環境。

數位PCR市場促進因素

受醫療保健領域對精準診斷工具需求不斷成長的推動，數位PCR市場正經歷顯著成長。隨著精準醫療的日益普及，對高靈敏度和高特異性檢測方法的需求也日益成長。數位PCR技術已被證明在臨床診斷和研究中具有巨大優勢，因為它能夠準確檢測基因突變、癌症生物標記和感染疾病。高品質的診斷在製定個人化治療方案中發揮關鍵作用，進一步提升了對個人化治療方法的需求。這種對更高診斷準確性的追求正在推動數位PCR市場的顯著擴張。

數位PCR市場面臨的限制因素

數位PCR市場面臨許多挑戰，主要在於所需設備和耗材成本高。小規模實驗室，尤其是經濟低度開發地區的實驗室，可能難以承擔技術和材料所需的投資。這種經濟障礙限制了尖端診斷工具的普及，導致醫療機構採用率低。因此，許多醫療專業人員可能選擇更經濟實惠的傳統PCR方法，而成本問題限制著創新技術的普及，最終可能阻礙整個數位PCR產業的成長和發展。

數位PCR市場趨勢

數位PCR市場正經歷一個顯著的趨勢，即機器學習（ML）和人工智慧（AI）技術的融合。這些技術的進步顯著提升了數據處理能力，從而能夠對複雜的基因數據進行精準分析。人工智慧演算法可以自動執行常規任務並最佳化實驗設計，提高工作流程效率和生產力。此外，透過機器學習增強的預測建模有助於更深入地了解基因突變和疾病機制。這些技術的整合不僅加速了各領域先進診斷工具的開發，也拓展了數位PCR儀器的應用範圍和實用性，從而推動了市場成長和創新。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Bio-Rad Laboratories, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）
QIAGEN NV（Germany/Netherlands）
F. Hoffmann-La Roche AG（Switzerland）
Merck KGaA（Germany）
Danaher Corporation（USA）
Sysmex Corporation（Japan）
JN Medsys Pte. Ltd.（Singapore）
Stilla Technologies SAS（France）
Standard BioTools Inc.（USA）
Fluidigm Corporation（USA）
Avance Biosciences（USA）
Takara Bio Inc.（Japan）
Meridian Bioscience（USA）
Becton, Dickinson and Company（USA）
Abbott Laboratories（USA）
Promega Corporation（USA）
Endress+Hauser Group Services AG（Switzerland）
Biomerieux（France）
Eppendorf AG（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35G2206

Digital PCR Market size was valued at USD 9.09 Billion in 2024 and is poised to grow from USD 9.95 Billion in 2025 to USD 20.57 Billion by 2033, growing at a CAGR of 9.5% during the forecast period (2026-2033).

The global digital PCR market is experiencing notable growth, driven by the increasing need for precise and sensitive nucleic acid quantification and analysis. This innovative technology is essential for research, disease diagnosis, and genetic testing owing to its unmatched accuracy and sensitivity. The market aims to deliver advanced molecular diagnostic solutions that empower healthcare professionals and researchers to achieve reliable results, ultimately enhancing patient care and fostering scientific advancements. Key market drivers include rising cases of infectious diseases and genetic disorders, a growing demand for personalized medicine, and significant advancements in genomic research. While challenges such as high costs and limited user knowledge persist, advancements like multiplex digital PCR assays and integration with next-generation sequencing are shaping a robust and evolving landscape in digital PCR.

Top-down and bottom-up approaches were used to estimate and validate the size of the Digital PCR market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Digital PCR Market Segments Analysis

Global Digital PCR Market is segmented by Type, Product, Technology, Indication, Application, End User and region. Based on Type, the market is segmented into Quantitative, Digital and End-point. Based on Product, the market is segmented into Consumables & Reagents, Digital PCR Instruments and Software & Services. Based on Technology, the market is segmented into Droplet Digital PCR, Chip-based Digital PCR and Others. Based on Indication, the market is segmented into Oncology, Infectious Disease, Genetic Disorders and Others. Based on Application, the market is segmented into Clinical Applications, Research Applications, Forensic Applications, Environmental Applications and Other Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Digital PCR Market

The digital PCR market is experiencing significant growth driven by the increasing need for precise diagnostic tools within the healthcare sector. As the focus shifts toward precision medicine, there is a rising demand for testing methods that offer high sensitivity and specificity. Digital PCR technology proves to be exceptionally beneficial for clinical diagnostics and research, enabling the accurate detection of genetic alterations, cancer biomarkers, and infectious diseases. Quality diagnostics play a crucial role in personalizing treatment plans, further enhancing the demand for tailored therapeutic approaches. This quest for greater diagnostic accuracy is propelling substantial expansion within the digital PCR market.

Restraints in the Digital PCR Market

The digital PCR market faces significant challenges primarily due to the high expenses associated with the necessary equipment and consumables. Smaller laboratories, especially in economically disadvantaged regions, may find the financial investment required for the technology and materials prohibitively expensive. This financial hurdle can limit access to cutting-edge diagnostic tools, leading to a slower adoption rate among healthcare providers. Consequently, many practitioners might choose to rely on more affordable traditional PCR methods, which could ultimately hinder the overall growth and advancement of the digital PCR industry, as the transition to innovative technologies remains constrained by cost-related issues.

Market Trends of the Digital PCR Market

The digital PCR market is experiencing a notable trend driven by the integration of machine learning (ML) and artificial intelligence (AI) technologies. These advancements significantly enhance data processing capabilities, allowing for accurate analysis of intricate genetic data. By automating routine tasks and optimizing experimental designs, AI algorithms improve workflow efficiency and productivity. Additionally, machine learning's ability to enhance predictive modeling fosters deeper insights into genetic variants and disease mechanisms. This convergence of technologies not only accelerates the development of sophisticated diagnostic tools across various sectors but also broadens the applicability and usability of digital PCR devices, propelling market growth and innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis

Global Digital PCR Market Size by Type & CAGR (2026-2033)

Market Overview
Quantitative
Digital
End-point

Global Digital PCR Market Size by Product & CAGR (2026-2033)

Market Overview
Consumables & Reagents
Digital PCR Instruments
Software & Services

Global Digital PCR Market Size by Technology & CAGR (2026-2033)

Market Overview
Droplet Digital PCR
Chip-based Digital PCR
Others

Global Digital PCR Market Size by Indication & CAGR (2026-2033)

Market Overview
Oncology
Infectious Disease
Genetic Disorders
Others

Global Digital PCR Market Size by Application & CAGR (2026-2033)

Market Overview
Clinical Applications
Research Applications
Forensic Applications
Environmental Applications
Other Applications

Global Digital PCR Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Forensic Laboratories
Other End Users

Global Digital PCR Market Size & CAGR (2026-2033)

North America (Type, Product, Technology, Indication, Application, End User)
- US
- Canada
Europe (Type, Product, Technology, Indication, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product, Technology, Indication, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product, Technology, Indication, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product, Technology, Indication, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany/Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JN Medsys Pte. Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stilla Technologies SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avance Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endress+Hauser Group Services AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments